COF
48
3
NDAQ
46
2
NRG
32
5
OKE
61
2
PLD
35
5
FIS
43
5
AMGN
42
14
VMC
41
2
KMI
69
8
R
55
-2
EQIX
59
2
EXPD
29
2
MKC
54
3
PRU
39
3
DG
14
6
NTRS
35
10
ITW
45
2
BMY
40
-5
EIX
61
8
CVX
25
14
COF
48
3
NDAQ
46
2
NRG
32
5
OKE
61
2
PLD
35
5
FIS
43
5
AMGN
42
14
VMC
41
2
KMI
69
8
R
55
-2
EQIX
59
2
EXPD
29
2
MKC
54
3
PRU
39
3
DG
14
6
NTRS
35
10
ITW
45
2
BMY
40
-5
EIX
61
8
CVX
25
14
Financhill
Back

Edgewise Therapeutics 10K Form

Sell
48

EWTX
Edgewise Therapeutics

Last Price:
$30.05
Seasonality Move:
26.98%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive EWTX News And Ratings

See the #1 stock for the next 7 days that we like better than EWTX

EWTX Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $-27.9M
Price / Cash Flow: 0
Annual Sales: $5.18
Price / Book: 5.95

Profitability

EPS (TTM): -1.49680
Net Income (TTM): $-124.3M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Edgewise Therapeutics Earnings Forecast

Key Edgewise Therapeutics Financial Ratios

  • Per Share Earnings over the last 5 years have been positive in 1 years.

Edgewise Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: EWTX
Website: edgewisetx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

EWTX Technical Analysis vs Fundamental Analysis

Sell
48
Edgewise Therapeutics (EWTX) is a Sell

Is Edgewise Therapeutics a Buy or a Sell?